In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from Blood
Open Access
- 1 January 2003
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (1), 78-83
- https://doi.org/10.1128/jcm.41.1.78-83.2003
Abstract
We determined the in vitro susceptibilities of 314 strains of Candida spp., representing 13 species rarely isolated from blood, to posaconazole and voriconazole as well as four licensed systemic antifungal agents (amphotericin B, flucytosine, fluconazole, and itraconazole). The organisms included 153 isolates of C. krusei , 67 isolates of C. lusitaniae , 48 isolates of C. guilliermondii , 10 isolates of C. famata , 10 isolates of C. kefyr , 6 isolates of C. pelliculosa , 5 isolates of C. rugosa , 4 isolates of C. lipolytica , 3 isolates of C. dubliniensis , 3 isolates of C. inconspicua , 2 isolates of C. sake , and 1 isolate each of C. lambica , C. norvegensis , and C. zeylanoides . MIC determinations were made by the National Committee for Clinical Laboratory Standards reference broth microdilution method and Etest (amphotericin B). Resistance to both amphotericin B and fluconazole was observed in strains of C. krusei , C. lusitaniae , C. guilliermondii , C. inconspicua , and C. sake . Resistance to amphotericin B, but not to fluconazole, was also observed among isolates of C. kefyr and C. rugosa . Posaconazole and voriconazole were active (MIC, ≤1 μg/ml) against 94 to 100% of these isolates. In contrast to the more common species of Candida causing bloodstream infection, these rare species appear to be less susceptible to the currently licensed systemic antifungal agents, with the exception of voriconazole. Continued surveillance will be necessary to detect the emergence of these species as more prevalent, resistant pathogens. The new triazoles appear to offer acceptable coverage of uncommon Candida sp. bloodstream infections.Keywords
This publication has 44 references indexed in Scilit:
- Transient Fungemia Caused by an Amphotericin B-Resistant Isolate of Candida haemuloniiJournal of Clinical Microbiology, 2002
- Antifungal Chemoprophylaxis after Blood and Marrow TransplantationClinical Infectious Diseases, 2002
- Catheter-Related Candidemia Caused by Candida lipolytica in a Patient Receiving Allogeneic Bone Marrow TransplantationJournal of Clinical Microbiology, 2002
- Improved Detection of Amphotericin B-Resistant Isolates of Candida lusitaniae by EtestJournal of Clinical Microbiology, 2001
- Practice Guidelines for the Treatment of CandidiasisClinical Infectious Diseases, 2000
- In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.Journal of Antimicrobial Chemotherapy, 1999
- National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE ProgramDiagnostic Microbiology and Infectious Disease, 1998
- Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniaeDiagnostic Microbiology and Infectious Disease, 1994
- Candida krusei FungemiaMedicine, 1993
- Candida lusitaniae infection in the newbornThe Pediatric Infectious Disease Journal, 1992